Fundraising Fox

David Sourdive

Investor

Venture Partner at Elaia

Greater Paris Metropolitan Region

About

PhD molecular virologist David Sourdive co-founded Cellectis (1999) and as EVP led technical operations through industrialization and public markets, focusing on Digital Life Sciences as engineerable, data-rich systems.

Invests in

AI & Machine LearningCybersecurityDeep TechHardwareHealthtechSaaS

Experience

  1. CellectisCo-founder, Executive Vice-President CMC & Manufacturingcurrent2020 — presentParis, Île-de-France, France
  2. CellectisCo-founder, Executive Vice President, Strategic Initiatives2019 — 2024
  3. CellectisExecutive Vice President Technical Operations2017 — 2024Paris, France
  4. CellectisExecutive Vice President - Corporate Development2008 — 2024
  5. CellectisVice President Business Development2006 — 2008
  6. CellectisChief Operations Officer2000 — 2006
  7. Direction générale de l'armementHead of Biotechnology Laboratory1998 — 2000Centre d'Etudes du Bouchet

Education

  1. Institut PasteurDoctor of Philosophy (PhD), Virology1990 — 1996
  2. Emory UniversityPost-Doctoral training, Immunology1997 — 1998
  3. École PolytechniqueBachelor of Science (BS), Physics1986 — 1989

Skills & more

Entrepreneurship5Life Science Industry5Biotechnology4Immunology3Molecular Virology2Business Development4Corporate Development4Sciences de la vie1Secteur pharmaceutiqueStratégie1Transfert technologiqueOncologie

From David's professional profile.

Colleagues at Elaia

Frequently asked questions

Where does David Sourdive work?
David Sourdive is Venture Partner at Elaia.
What does David Sourdive invest in?
David Sourdive invests in AI & Machine Learning, Cybersecurity, Deep Tech, Hardware, Healthtech, SaaS.

Founder mafias

Same school

Shared employers